AllianceBernstein’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $559K | Sell |
45,240
-6,820
| -13% | -$70.6K | ﹤0.01% | 2583 |
|
|
2025
Q4 | $643K | Buy |
52,060
+32,980
| +173% | +$353K | ﹤0.01% | 2535 |
|
|
2025
Q3 | $168K | Hold |
19,080
| – | – | ﹤0.01% | 3120 |
|
|
2025
Q2 | $122K | Buy |
+19,080
| New | +$109K | ﹤0.01% | 3143 |
|
|
2024
Q2 | – | Sell |
-54,000
| Closed | -$137K | – | 3256 |
|
|
2024
Q1 | $137K | Sell |
54,000
-6,464
| -11% | -$14.6K | ﹤0.01% | 2992 |
|
|
2023
Q4 | $145K | Sell |
60,464
-28,191
| -32% | -$66.2K | ﹤0.01% | 3021 |
|
|
2023
Q3 | $301K | Sell |
88,655
-3,789
| -4% | -$21K | ﹤0.01% | 2805 |
|
|
2023
Q2 | $679K | Hold |
92,444
| – | – | ﹤0.01% | 2481 |
|
|
2023
Q1 | $958K | Sell |
92,444
-86,553
| -48% | -$1.05M | ﹤0.01% | 2253 |
|
|
2022
Q4 | $2.11M | Buy |
178,997
+30,043
| +20% | +$465K | ﹤0.01% | 1886 |
|
|
2022
Q3 | $3.13M | Buy |
148,954
+50,008
| +51% | +$1.39M | ﹤0.01% | 1619 |
|
|
2022
Q2 | $3.07M | Sell |
98,946
-40,004
| -29% | -$1.37M | ﹤0.01% | 1691 |
|
|
2022
Q1 | $5.71M | Buy |
138,950
+40,578
| +41% | +$1.79M | ﹤0.01% | 1521 |
|
|
2021
Q4 | $4.28M | Sell |
98,372
-58,183
| -37% | -$2.63M | ﹤0.01% | 1702 |
|
|
2021
Q3 | $7.84M | Buy |
156,555
+18,465
| +13% | +$1.12M | ﹤0.01% | 1375 |
|
|
2021
Q2 | $8.7M | Sell |
138,090
-3,560
| -3% | -$229K | ﹤0.01% | 1306 |
|
|
2021
Q1 | $13.2M | Buy |
141,650
+424
| +0.3% | +$43.4K | 0.01% | 1081 |
|
|
2020
Q4 | $12.7M | Sell |
141,226
-1,264
| -0.9% | -$116K | 0.01% | 1023 |
|
|
2020
Q3 | $14.7M | Buy |
142,490
+20,597
| +17% | +$2.22M | 0.01% | 901 |
|
|
2020
Q2 | $9.64M | Buy |
121,893
+9,890
| +9% | +$737K | 0.01% | 1019 |
|
|
2020
Q1 | $6.48M | Sell |
112,003
-6,518
| -5% | -$376K | ﹤0.01% | 1073 |
|
|
2019
Q4 | $6.39M | Buy |
118,521
+200
| +0.2% | +$10.8K | ﹤0.01% | 1290 |
|
|
2019
Q3 | $6.19M | Sell |
118,321
-12,950
| -10% | -$603K | ﹤0.01% | 1263 |
|
|
2019
Q2 | $6.34M | Buy |
131,271
+18,400
| +16% | +$882K | ﹤0.01% | 1268 |
|
|
2019
Q1 | $5.7M | Buy |
112,871
+4,339
| +4% | +$256K | ﹤0.01% | 1305 |
|
|
2018
Q4 | $6.43M | Sell |
108,532
-18,248
| -14% | -$1.18M | ﹤0.01% | 1188 |
|
|
2018
Q3 | $8.35M | Buy |
126,780
+21,908
| +21% | +$1.28M | 0.01% | 1038 |
|
|
2018
Q2 | $5.29M | Buy |
104,872
+17,400
| +20% | +$907K | ﹤0.01% | 1208 |
|
|
2018
Q1 | $4.61M | Hold |
87,472
| – | – | ﹤0.01% | 1263 |
|
|
2017
Q4 | $4.07M | Sell |
87,472
-4,900
| -5% | -$206K | ﹤0.01% | 1350 |
|
|
2017
Q3 | $3.74M | Sell |
92,372
-2,420
| -3% | -$87.6K | ﹤0.01% | 1398 |
|
|
2017
Q2 | $3.21M | Buy |
94,792
+45,280
| +91% | +$1.4M | ﹤0.01% | 1496 |
|
|
2017
Q1 | $1.44M | Hold |
49,512
| – | – | ﹤0.01% | 2043 |
|
|
2016
Q4 | $1.63M | Hold |
49,512
| – | – | ﹤0.01% | 1981 |
|
|
2016
Q3 | $1.56M | Sell |
49,512
-13,300
| -21% | -$386K | ﹤0.01% | 1956 |
|
|
2016
Q2 | $1.77M | Buy |
62,812
+7,660
| +14% | +$300K | ﹤0.01% | 1825 |
|
|
2016
Q1 | $2M | Buy |
55,152
+10,110
| +22% | +$357K | ﹤0.01% | 1614 |
|
|
2015
Q4 | $1.8M | Buy |
45,042
+230
| +0.5% | +$8.02K | ﹤0.01% | 1703 |
|
|
2015
Q3 | $1.28M | Sell |
44,812
-70
| -0.2% | -$2.31K | ﹤0.01% | 1996 |
|
|
2015
Q2 | $1.48M | Buy |
44,882
+2,700
| +6% | +$83.7K | ﹤0.01% | 2041 |
|
|
2015
Q1 | $1.21M | Sell |
42,182
-2,200
| -5% | -$63.1K | ﹤0.01% | 2087 |
|
|
2014
Q4 | $1.21M | Hold |
44,382
| – | – | ﹤0.01% | 2092 |
|
|
2014
Q3 | $946K | Hold |
44,382
| – | – | ﹤0.01% | 2231 |
|
|
2014
Q2 | $997K | Sell |
44,382
-10
| -0% | -$233 | ﹤0.01% | 2260 |
|
|
2014
Q1 | $1.12M | Sell |
44,392
-3,280
| -7% | -$82.8K | ﹤0.01% | 2097 |
|
|
2013
Q4 | $1.1M | Buy |
47,672
+34
| +0.1% | +$709 | ﹤0.01% | 2104 |
|
|
2013
Q3 | $908K | Sell |
47,638
-561
| -1% | -$10K | ﹤0.01% | 2178 |
|
|
2013
Q2 | $695K | Buy |
+48,199
| New | +$698K | ﹤0.01% | 2286 |
|
Other funds holding EBS
VCM
PCM
VPM
AllianceBernstein's EBS Position: Q1 2026 in Review
AllianceBernstein reduced its Emergent Biosolutions (EBS) stake by 13% in Q1 2026, selling an estimated $70.6K and leaving 45,240 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #2583.
AllianceBernstein first reported a position in EBS in Q2 2013 and has held it in 48 quarters since. The position peaked at $14.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- AllianceBernstein held 45,240 shares of Emergent Biosolutions worth $559K as of Q1 2026.
- AllianceBernstein sold 6,820 Emergent Biosolutions shares in Q1 2026, an estimated $70.6K.
- Emergent Biosolutions made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2583 holding.
- AllianceBernstein first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 48 quarters since.
- AllianceBernstein's Emergent Biosolutions position peaked at $14.7M in Q3 2020.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.